NPS Rejiggers Amgen Deal, Sees $75M Extra Cash

Arlene Weintraub Bedminster,NJ-based NPS Pharmaceuticals (NASDAQ: NPSP) said today it had amended its licensing agreement with biotech giant Amgen (NASDAQ: AMGN) for sales of cinacalcet HC…
Read the full story: Xconomy Life Sciences